Results 171 to 180 of about 601,176 (342)

Inhibition of CDK9 enhances AML cell death induced by combined venetoclax and azacitidine

Molecular Oncology, EarlyView.
The CDK9 inhibitor AZD4573 downregulates c‐MYC and MCL‐1 to induce death of cytarabine (AraC)‐resistant AML cells. This enhances VEN + AZA‐induced cell death significantly more than any combination of two of the three drugs in AraC‐resistant AML cells.
Shuangshuang Wu, Jianlei Zhao, Aaban Asfar Azmi, Avanti Gupte, Jenna Thibodeau, Shuang Liu, Jinli Yang, Guan Wang, Holly Edwards, Lisa A. Polin, Juiwanna Kushner, Sijana H. Dzinic, Kathryn White, Julie Boerner, Maik Hüttemann, Jay Yang, Yue Wang, Jeffrey W. Taub, Yubin Ge   +18 more
wiley   +1 more source

Effectiveness of Different Kidney Exchange Mechanisms on Improving Living Donor Transplantation in Chile [PDF]

Chile has a very low cadaveric organ donation rate; at the same time, living donor transplantation activity is low. The purpose of this paper is to analyze the impact on the number and quality of transplants of the potential application of different ...
Diego Contreras, Javier Dominguez
core  

Development of a national minimum data set to monitor deceased organ donation performance in Canada [PDF]

, 2019
Karen Hornby, Sam D. Shemie, Amber Appleby, Nancy G. Dodd, Jaghir Gill, S. Joseph Kim, Andreas H. Kramer, Demetrios J. Kutsogiannis, Nick Lahaie, Janet R. MacLean, Louise Rehel, Greg Webster, Juliana Wu, Damon C. Scales   +13 more
openalex   +1 more source

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Defaults and Donation Decisions [PDF]

, 2004
Eric J. Johnson, Daniel G. Goldstein
openalex   +1 more source

Voluntary blood donation promotion in Haute Matsiatra region of Madagascar

, 2021
Jocia Fenomanana, Heritiana Gisèle Ramaminiaina, Fidiniaina Mamy Randriatsarafara, Zely Arivelo Randriamanantany   +3 more
openalex   +2 more sources

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

A social ecological model mapping of factors shaping health personnel's attitudes toward organ donation: a scoping review. [PDF]

BMC Health Serv Res
Zhou H, Zhang X, Li M, Li R, Huang J.
europepmc   +1 more source

A comparative observational study of Ayurveda bloodletting procedure and blood donation with special reference to RBC indices in healthy individuals

, 2023
Nirmala Sawarkar, Pallavi Ghadage, Govardhan Sahani, Antony Stephen Raj, Arun Prakash, Mydeen Mydeen Sadik   +5 more
openalex   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

Molecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker, Keren Zohar, Martin Böttcher, Thomas Wartmann, Henry Freudenstein, Maximilian Doelling, Mihailo Andric, Wenjie Shi, Or Kakhlon, Katrin Hippe, Beatrix Jahnke, Dimitrios Mougiakakos, Franziska Baenke, Daniel Stange, Roland S. Croner, Michal Linial, Ulf D. Kahlert   +16 more
wiley   +1 more source